Early research (Phase 1)Study completedNCT02668393What this trial is testingNintedanib and Weekly Docetaxel in Lung AdenocarcinomaWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 14
Early research (Phase 1)UnknownNCT05369312What this trial is testingPhase 1 Study of BPI-442096 in Advanced Solid Tumor PatientsWho this might be right forSolid TumorNon-small Cell Lung CancerPancreatic Cancer+1 more Betta Pharmaceuticals Co., Ltd. 230
Testing effectiveness (Phase 2)Study completedNCT01708993What this trial is testingReolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage TherapyWho this might be right forNon Small Cell Lung Cancer Canadian Cancer Trials Group 166
Large-scale testing (Phase 3)Active Not RecruitingNCT05170204What this trial is testingA Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 68
Testing effectiveness (Phase 2)UnknownNCT02815007What this trial is testingChidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerWho this might be right forAdvanced EGFR-TKI-resistant Non-Small Cell Lung Cancer Yuankai Shi 20
Not applicableStudy completedNCT07243899What this trial is testingMultimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and ChemotherapyWho this might be right forNSCLC Shanghai Zhongshan Hospital 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Testing effectiveness (Phase 2)UnknownNCT04903873What this trial is testingEvaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsWho this might be right forSolid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more Eutilex 110
Testing effectiveness (Phase 2)Looking for participantsNCT07670312What this trial is testingEvaluation of XYA02 in Patients With Advanced Solid TumorsWho this might be right forMUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more XYone Therapeutics, Inc 190
Testing effectiveness (Phase 2)WithdrawnNCT00048087What this trial is testingIressa/Docetaxel in Non-Small-Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04900363What this trial is testingA Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLCWho this might be right forNon-small Cell Lung Cancer Akeso 108
Early research (Phase 1)Looking for participantsNCT07130916What this trial is testingAumolertinib in European Participants With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Post-approval studies (Phase 4)UnknownNCT02404675What this trial is testingHigh Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon MutationWho this might be right forNSCLC Betta Pharmaceuticals Co., Ltd. 240
Early research (Phase 1)Study completedNCT03421353What this trial is testingAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerWho this might be right forAdvanced Solid Tumours AstraZeneca 76
Very early researchUnknownNCT05886075What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsWho this might be right forLung CancerBronchial CancerNon Small Cell Lung Cancer+9 more Shanghai Yunying Medical Technology 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Looking for participantsNCT05766800What this trial is testingInduction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung CancerWho this might be right forLocally AdvancedNon-small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 100
Testing effectiveness (Phase 2)Study completedNCT01924195What this trial is testingPhase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）Who this might be right forNon-small Cell Lung Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 117
Early research (Phase 1)WithdrawnNCT01004419What this trial is testingTrial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non Small Cell Lung University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT00243867What this trial is testingTaxoprexin Plus Carboplatin Treatment for Advanced Lung CancerWho this might be right forNon-Small Cell Lung Cancer American Regent, Inc. 518